About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback